Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Drake

Showing results (331-340 of 456) with videos related to

Pageof 46
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.
The Prostate|August 12, 2020
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for cliniciansNeal D Shore, Charles G Drake, Daniel W Lin, et al.
The Journal of Clinical Investigation|October 13, 2007
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systemsJoseph F Grosso, Cristin C Kelleher, Timothy J Harris, et al.
Seminars in Oncology|November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamideHarshraj Leuva, Keith Sigel, Mengxi Zhou, et al.
Prostate Cancer and Prostatic Diseases|December 6, 2017
Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP modelYing-Chun Shen, Ali Ghasemzadeh, Christina M Kochel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunityTimothy J Harris, Joseph F Grosso, Hung-Rong Yen, et al.
Molecular Immunology|March 16, 2010
A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cellsDerese Getnet, Joseph F Grosso, Monica V Goldberg, et al.
Science (New York, N.Y.)|August 22, 2009
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cellsFan Pan, Hong Yu, Eric V Dang, et al.
Annals of Surgical Oncology|March 26, 2016
Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical CystectomyHeather J Chalfin, Jen-Jane Liu, Nilay Gandhi, et al.
Immunity|October 16, 2004
Role of LAG-3 in regulatory T cellsChing-Tai Huang, Creg J Workman, Dallas Flies, et al.
Pageof 46

Showing results (331-340 of 456) with videos related to

Sort By:
Pageof 46
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.
The Prostate|August 12, 2020
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for cliniciansNeal D Shore, Charles G Drake, Daniel W Lin, et al.
The Journal of Clinical Investigation|October 13, 2007
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systemsJoseph F Grosso, Cristin C Kelleher, Timothy J Harris, et al.
Seminars in Oncology|November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamideHarshraj Leuva, Keith Sigel, Mengxi Zhou, et al.
Prostate Cancer and Prostatic Diseases|December 6, 2017
Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP modelYing-Chun Shen, Ali Ghasemzadeh, Christina M Kochel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunityTimothy J Harris, Joseph F Grosso, Hung-Rong Yen, et al.
Molecular Immunology|March 16, 2010
A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cellsDerese Getnet, Joseph F Grosso, Monica V Goldberg, et al.
Science (New York, N.Y.)|August 22, 2009
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cellsFan Pan, Hong Yu, Eric V Dang, et al.
Annals of Surgical Oncology|March 26, 2016
Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical CystectomyHeather J Chalfin, Jen-Jane Liu, Nilay Gandhi, et al.
Immunity|October 16, 2004
Role of LAG-3 in regulatory T cellsChing-Tai Huang, Creg J Workman, Dallas Flies, et al.
Pageof 46